Joaquin Sosa
Senior Director, Clinical Systems & Trial Management at Cidara Therapeutics | Austin, Texas, United States
Joaquin Sosa’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Senior Director, Clinical Systems & Trial Management at Cidara Therapeutics in February 2023 - Present
Director, Clinical Systems & Trial Management at Cidara Therapeutics in April 2022 - February 2023
Director, Clinical Document Management at Cidara Therapeutics in January 2021 - April 2022
Director, TMF Operations at Syneos Health Clinical Solutions (Previously INC Research/inVentiv Health) in October 2019 - January 2021
Associate Director, TMF Operations at Syneos Health Clinical Solutions (Previously INC Research/inVentiv Health) in June 2018 - October 2019
Project Manager II at Syneos Health Clinical Solutions (Previously INC Research/inVentiv Health) in January 2018 - May 2018
Project Manager II at INC Research in January 2016 - December 2017
Sr. Director of Clinical Operations at Pioneer Research Solutions, Inc. in May 2013 - January 2016
Director of Operations at Austin Center for Clinical Research in January 2011 - January 2016
Clinical Research Associate at Kforce Clinical Research, Inc. in February 2008 - December 2010
Sr. Project Research Associate at i3 Research in November 2007 - February 2008
CRA III at PPD in January 2007 - October 2007
CRA II at PPD in January 2006 - January 2007
CRA I at PPD in November 2004 - January 2006
Sr. Research Technician at PPD in January 2002 - November 2004
RN II at Seton Medical Center in December 2003 - November 2004
Research Technician at PPD in May 2001 - January 2002
University of Illinois at Urbana-Champaign, Master of Business Administration (M.B.A.), January 2016 to January 2017
Concordia University-Austin, Bachelor of Arts, January 2011 to January 2012
Austin Community College, AASN, January 1999 to January 2003
Cidara Therapeutics is using its proprietary Cloudbreak® platform to develop novel DFCs comprising targeted small molecules or peptides coupled to a proprietary human antibody fragment. Cidara’s lead DFC candidate, CD388, is a long-acting antiviral designed to achieve universal prevention of seasonal and pandemic influenza with a single dose by directly inhibiting viral proliferation.
Discover more about Cidara Therapeutics
Executive at Cidara Therapeutics
Senior Vice President, People and Culture at Cidara Therapeutics
(Feb 2015 – Present)
Chief Financial Officer at Cidara Therapeutics
Chief Financial Officer at Cidara Therapeutics
(Feb 2025 – Present)
Green Flash Capital
Founder, Managing Partner at Green Flash Capital
(Jun 2026 – Present)
Vice President Technical Operations at Cidara Therapeutics, Inc., a subsidiary of Merck & Co., Inc.
Vice President Technical Operations at Cidara Therapeutics
(Jan 2023 – Present)
Independent Consultant | Biotech Leader | Bioprocessing expert | PD | Industrialization | TT | CMC | PMP certified
Leading technology transfer (TT) efforts at a new CDMO, providing strategic oversight of USP and DSP activities for an ADC. Simultaneously, I oversee critical Process Validation milestones underway with an external partner in Asia—including process characterization and PPQ p...
Consultant
Chief Scientific Officer at Cidara Therapeutics
(Jul 2021 – Present)
What is Joaquin Sosa email address?
Email Joaquin Sosa at [email protected] and [email protected]. This email is the most updated Joaquin Sosa's email found in 2026.
How to contact Joaquin Sosa?
To contact Joaquin Sosa send an email to [email protected] or [email protected].
What company does Joaquin Sosa work for?
Joaquin Sosa works for Cidara Therapeutics.
What is Joaquin Sosa's role at Cidara Therapeutics?
Joaquin Sosa is Senior Director, Clinical Systems & Trial Management
What industry does Joaquin Sosa work in?
Joaquin Sosa works in the Pharmaceuticals industry.
